Ron Gutman | Source | CEO & Founder & Stanford University Professor at Intrivo
Ron Gutman
Serial healthcare and technology entrepreneur, renowned innovator investor, Stanford adjunct professor, and modern leader, Ron Gutman continues to reinvent the healthcare industry one technology company at a time. Ron has built companies that have helped hundreds of millions of people worldwide. As an inventor with patents in healthcare technology and AI, he is dedicated to transforming the healthcare industry by optimizing technology to make it more accessible, personal, and delightful. He currently leads Intrivo, a global healthcare technology company. Previously, Ron was the CEO of HealthTap, the market-leading virtual healthcare provider in the US, and founder of Wellsphere, an online consumer health company that grew to become one of the largest health websites. Ron’s mission-driven philosophy is embodied in On/Go for Good, the charitable arm of Intrivo that allows further support for those most in need, particularly groups who may not be able to afford treatment or lack adequate health insurance.
-
Intrivo
CEO & Founder & Stanford University Professor -
Stanford University
Adjunct Professor
-
Health Tech Leader On/Go™ (by Intrivo) Launches "Test to Treat" Solution for COVID-19, Providing Rapid Home Delivery of Antiviral Medication, and Long COVID Support
/PRNewswire/ -- Intrivo, the leading health technology company behind On/Go rapid COVID-19 tests and the AI-powered mobile app, today announced the launch of...
Article
-
We now have more tools to control the spread of COVID-19 more effectively than before, but it's not always easy for people to access them quickly, easily, and affordably. With our Test-to-Treat solution, we ensure that eligible people who really need Paxlovid can start their antiviral prescriptions almost immediately because we know time is of the essence and we have the leading edge technology to deliver it. When someone tests positive, they may not know what to do next – from test results to prescription fulfillment to rapid delivery to lingering symptoms, we've got our users' backs and can help them control COVID-19 for good.
